Martina Burke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martina Burke has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Colin J. Sutherland
London School of Hygiene & Tropical Medicine
1 shared publication - Geoffrey Pasvol
Wellcome Centre for Clinical Tropical Medicine, Imperial College London, London, United Kingdom
1 shared publication - John L. Klein
Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London, UK
1 shared publication - Matt Laundy
Department of Clinical Parasitology, Hospital for Tropical Diseases, Mortimer Market, Capper St, London, WC1E 6AU, UK
1 shared publication - Nicholas Martin Price
Directorate of Infection, Guy's & St Thomas' NHS Foundation Trust, London, UK
1 shared publication - Peter L. Chiodini
Department of Clinical Parasitology, Hospital for Tropical Diseases, London, UK
1 shared publication
Latest Publications
- Open Access
- 20 November 2008
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 240
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
Fixed-dose combination antimalarial drugs have played an increasingly important role in the treatment and chemoprophylaxis of falciparum malaria since the worldwide failure of monotherapy with chloroquine. Atovaquone-proguanil is one such combination drug used both for prophylaxis in travellers, and for treatment of acute malaria cases in European hospitals and clinics.
- 20 November 2008
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 240
Open AccessMutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
Fixed-dose combination antimalarial drugs have played an increasingly important role in the treatment and chemoprophylaxis of falciparum malaria since the worldwide failure of monotherapy with chloroquine. Atovaquone-proguanil is one such combination drug used both for prophylaxis in travellers, and for treatment of acute malaria cases in European hospitals and clinics.